iCrowd Newswire – Jun 23, 2020
Medical foods and dietary supplements are used to treat rare inborn errors of metabolism (IEM) identified through state-based universal newborn screening. Inborn errors of metabolism are genetic disorders and are characterized by deficient metabolism (breakdown) of protein, carbohydrate, or fat. These defects may be congenital or manifest shortly after birth, resulting in the build-up of toxic chemicals in the body, causing severe malnutrition, nerve damage, mental retardation, or death. Medical foods are designed for patients, including the limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foods or nutrients, and dietary management cannot be achieved by modification of the healthy diet alone.
The medical foods for inborn errors of metabolism market are driving due to the increasing expenditure on medical food along with the introduction of innovative products for new indications. However, inadequate reimbursement scenario is expected to restraint the usage of therapeutic food and is expected to slow down the growth of the medical food market in the forecasted period. Moreover, the rising incidence of inborn errors of metabolism, preference of dietary supplements over enzyme substitution therapy is the major drivers that propelled the demand of the market in the forecast period.
Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00011389/
The report also includes the profiles of key players in medical foods for inborn errors of metabolism market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Nestlé Health Science
- Solace Nutrition
- Mead Johnson and Company, LLC.
- BioMarin Pharmaceutical
- Ajinomoto Cambrooke, Inc.
- Poa Pharma
- Primus Pharmaceuticals, Inc.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the medical foods for inborn errors of metabolism market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The medical foods for inborn errors of metabolism market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The “Medical Foods for Inborn Errors of Metabolism Market Analysis to 2027” is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of medical foods for inborn errors of metabolism market with detailed market segmentation by of product, age group, disease, forms, packaging and distribution channel. The medical foods for inborn errors of metabolism market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in medical foods for inborn errors of metabolism market and offers key trends and opportunities in the market.
The medical foods for inborn errors of metabolism market is segmented on the basis of product, age group, disease, forms, packaging and distribution channel. Based on product, the market is segmented as amino acid, glytactin with GMP, amino acid-modified infant formula with iron, low-calcium/vitamin d-free infant formula with iron, low protein food, others. On the basis of age group, the market is categorized as infants, weaning, adolescent, adults. On the basis of disease, the market is categorized as phenylketonuria(PKU), maple syrup urine disease(MSUD), homocystinuria, urea cycle disorders , methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type i, renal disease, tyrosinemia types i and ii, others. On the basis of forms, the market is categorized as powder, liquids, gels , others. On the basis of packaging, the market is categorized as can, jar, packets, bottle, others. On the basis of distribution channel, the market is categorized as retail pharmacies, hospital pharmacies, online pharmacies, drugs store , other.
The report analyzes factors affecting medical foods for inborn errors of metabolism market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the medical foods for inborn errors of metabolism market in these regions.
Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00011389/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
Email: [email protected]